Pediatric Immunization

Latest News

FDA Approves PENBRAYA™, the First and Only Vaccine for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents  / Image credit FDA stamp ©Waldenmarus/stock.adobe.com
FDA Approves Pentavalent Meningococcal Vaccine from Pfizer for Ages 10 to 25 years

October 24th 2023

The Pfizer product is the first vaccine indicated to prevent the 5 most common serogroups causing meningococcal disease in adolescents and young adults.

Nirsevimab Efficacy Against RSV-LRTI-Associated Hospitalization is Robust, Across Infant Subgroups / image credit ©RSV Kateryna_Kon/stock.adobe.com
IDWeek 2023: Nirsevimab Efficacy Against RSV-LRTI-Associated Hospitalization is Robust Across Infant Subgroups

October 15th 2023

 Death Often Follows First Opioid After Dementia Dx / Image Credit: ©New Africa/AdobeStock
Daily Dose: Characteristics of RSV-Related Critical Illness in Infants during 2022 Peak

August 23rd 2023

 Death Often Follows First Opioid After Dementia Dx / Image Credit: ©New Africa/AdobeStock
Daily Dose: AAP's 12 Tips to Prep Children for Back-to-School Season

August 21st 2023

US Infants Admitted to ICU in 2022 for RSV Mostly Young, Healthy, and Born at Term / Image credit: ©jakkapan/AdobeStock
US Infants Admitted to ICU in 2022 for RSV Mostly Young, Healthy, and Born at Term

August 18th 2023

Latest CME Events & Activities

Patient, Provider, and Caregiver Connection™: Challenges in Diagnosis and Management for Patients with ADHD During the COVID-19 Pandemic

View More

State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections

View More

FAQs in Peanut Allergy: Exploring Unanswered Questions Following Allergy Meeting Updates

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?

View More

Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients

View More

Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines

View More

Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?

View More

Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency

View More

Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations

View More

More News

© 2023 MJH Life Sciences

All rights reserved.